Navigation Links
Brainlab ExacTrac® System Achieves Major Sales Milestone
Date:1/16/2012

CHICAGO, Jan. 16, 2012 /PRNewswire/ -- Today Brainlab announced the 500th sale of its ExacTrac® patient positioning system for frameless radiosurgery. The scale of uptake highlights physicians continued focus on adopting clinically proven systems for high-precision cancer treatments and their ongoing investment in ensuring access to advanced radiation therapy for patients.

The ExacTrac® system, first developed almost a decade ago, has been proven consistent and reliable in supporting accurate frameless radiosurgery for patients with tumors of the brain, spine and beyond. The system has since been internationally recognized as offering high accuracy, flexibility and increased patient comfort during treatment. 

ExacTrac® works by combining with advanced radiosurgery treatment systems to allow physicians to treat cancers using a frameless radiosurgery technique. This offers a valuable alternative to the historical practice that requires immobilization with an invasive head ring affixed to the skull.[1] The advanced image guidance and computer-driven optimization of ExacTrac® enables physicians to control every step of the treatment pathway, improving workflow and flexibility of treatment planning.

Samuel Ryu, M.D., Director of Radiation Oncology at the Henry Ford Health System, comments on the evolution of cancer treatment to frameless radiosurgery:

"We have transitioned to frameless radiosurgery after conducting thorough scientific verifications of the precision of the technique. We have now widely adopted the technique and are applying protocols to treat more than 99 percent of our patients frameless."

By offering precision to a sub-millimeter level, ExacTrac® provides high accuracy during the entire procedure and helps reduce errors within the process, therefore maximizing overall treatment accuracy. By offering the option of non-invasive frame
'/>"/>

SOURCE Brainlab
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Brainlab Acquires Voyant Health
2. Brainlab and SurgiVision Announce Strategic Alliance in MRI-Guided Drug Delivery and Other Interventional MRI Technologies in Neurosurgery
3. Brainlab Launches Refreshed Website
4. Medtronic, Stryker, and BrainLAB Covered in New Surgical Navigation Market Research Reports Released by Millennium Research Group
5. Self Regional Healthcare Becomes First in the Southeast to Treat Spine Patients Using Advanced Integrated Operating Room Technology From Brainlab
6. Brainlab Offers Real-Time Monitoring for IGRT
7. Brainlab Collaborates With Toshiba Medical Systems on Integrated Surgical Suite
8. Slovenias Sole Radiotherapy Hospital Unveils Novalis Tx(TM) Platform From Varian and BrainLAB
9. St. Lukes Hospital Acquires Pioneering Technology From BrainLAB
10. Advanced Image-Guided Surgery Technology From BrainLAB Now Available in New York State
11. ONRAD, Inc. Chooses Dicom Systems Vendor Neutral Archive
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... , July 29, 2015  ViaCyte, Inc., a privately-held regenerative medicine ... treatment of diabetes in clinical trials, today announced the opening of ... or S afety, T olerability, and E fficacy ... Diabetes.  The new site, which is the first in ... in Edmonton , Alberta.  The ...
(Date:7/29/2015)... July 29, 2015  Fifty groups representing 500,000 patients, ... 29, to launch the AllTrials campaign in the US. ... present, and future, to be registered and the results ... Ben Goldacre explains: "Patients want the treatments ... evidence on what works. Unfortunately, we now know that ...
(Date:7/29/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/hmjqff/global_wound_care ) has ... Care Markets (Twelve Country Analysis: Germany, France, Italy, ... Brazil, Australia, South Korea)" report to their ... competitive market summary. The wound care market is ... product maturity. Several of the products within the ...
Breaking Medicine Technology:ViaCyte Announces Second Clinical Trial Site at University of Alberta 2ViaCyte Announces Second Clinical Trial Site at University of Alberta 3ViaCyte Announces Second Clinical Trial Site at University of Alberta 4Fixing Your Medicine: AllTrials Campaign Launches in US 2Fixing Your Medicine: AllTrials Campaign Launches in US 3Global Wound Care Markets 2015 2
... 29, 2011 , OBN BioCluster ... The UK bioindustry has raised over $250m in financing during the ... for one year, and the second largest amount raised in any ... financing drought that saw three consecutive quarters below $100m from the ...
... 29, 2011 Sales executives agree that delivering ... biopharmaceutical sales process. Yet despite the effectiveness of ... drug,s efficacy, only 6% of biopharmaceutical district sales ... of data to sales representatives, according to recent ...
Cached Medicine Technology:UK Chalks Up $253 Million in Investment in Q2 2011: Oxford Cluster Takes the Largest Bite of the Apple 2UK Chalks Up $253 Million in Investment in Q2 2011: Oxford Cluster Takes the Largest Bite of the Apple 3Though Essential to Pharmaceutical Sales Success, the Use of Health Outcomes Data Often Overlooked by Sales Leaders 2
(Date:7/29/2015)... CA (PRWEB) , ... July 29, 2015 , ... We are privileged to announce that ... Medicine of USC as the ninth best ophthalmology hospital in the nation for 2015-2016. This ... 10 American hospitals for ophthalmology. , “It is an honor to be included in ...
(Date:7/29/2015)... ... July 29, 2015 , ... Inspired by a successful ... Steven W. Meier M.D., a prominent orthopedic surgeon and regenerative medicine expert in ... financial need. , “We are thrilled for this opportunity to offer prolotherapy treatments ...
(Date:7/29/2015)... ... July 29, 2015 , ... Stealth ... a Clinical Performance Study for the Invisiport at Wheaton Franciscan Healthcare in Milwaukee, ... options, offers a less invasive, patient-friendly alternative to traditional chest ports and peripherally ...
(Date:7/29/2015)... ... July 29, 2015 , ... Zofran ... Judicial Panel on Multidistrict Litigation (JPML), according to court documents.* Attorneys handling ... website, the Zofran Birth Defects Lawsuit Center. , GlaxoSmithKline, the global pharmaceutical conglomerate ...
(Date:7/29/2015)... ... July 29, 2015 , ... The Woodlands and Spring ... lifestyles while donating to worthy charitable causes each month. The new system will track ... camp. For each Check In at each facility, the boot camps will donate 20 ...
Breaking Medicine News(10 mins):Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 2Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 3Health News:Orthopedic Surgeon Announces New Pro Bono Prolotherapy and Regenerative Medicine Clinic for Underserved Communities in Los Angeles 2Health News:Stealth Therapeutics Inc. Enrolls First Patients in a Clinical Performance Study for the Invisiport Product Line 2Health News:Stealth Therapeutics Inc. Enrolls First Patients in a Clinical Performance Study for the Invisiport Product Line 3Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 2Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 3Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 4Health News:Transforming Texan Lives and Bodies: Woodlands and Spring Fitness Boot Camps Commit to Multiple Charity Donations 2Health News:Transforming Texan Lives and Bodies: Woodlands and Spring Fitness Boot Camps Commit to Multiple Charity Donations 3
... your keys has its down sideSAN FRANCISCO, March 13 ... (Medical Sciences) indicate that convincing older drivers to give up ... study of 660 adults aged 63 to 97 showed that ... likely to die over a three-year period than their counterparts ...
... - The Boston Center for Refugee Health and ... treated many of the large number of Tibetan ... individuals arrived in Boston suffering from symptoms of ... monks were diagnosed by their traditional healers as ...
... - Haemacure Corporation (TSX : HAE) released today ... 31, 2009.ResultsRevenues amounted to $19,226, as compared to ... were exclusively derived from the sale of legacy ... $2.7 million, up from $1.2 million for the ...
... half of Americans know that the "better" fats (monounsaturated ... disease, according to a recent survey by the American ... at: http://inr.mediaseed.tv/aha_36307/ "Heart disease remains the No. ... lot about the ,bad, fats lately and what not ...
... occurred in ICUs , , THURSDAY, March 12 (HealthDay News) ... problem in intensive care units, a new study reveals. ... ICUs in 27 countries over a 24-hour period in ... included in the study. , Dr. Andreas Valentin of ...
... MESSA,s East Lansing-based ... consecutive year for superior efficiency and performance in providing ... providing efficient and effective customer service as measured against ... at Purdue University and BenchmarkPortal. "MESSA is ...
Cached Medicine News:Health News:Drive or Die 2Health News:Drive or Die 3Health News:Researchers discover ways of integrating treatment of traumatized Tibetan refugee monks 2Health News:Researchers discover ways of integrating treatment of traumatized Tibetan refugee monks 3Health News:Haemacure Reports First Quarter 2009 Results and Hires Advisor for the Sale or Merger of the Company 2Health News:Haemacure Reports First Quarter 2009 Results and Hires Advisor for the Sale or Merger of the Company 3Health News:VIDEO From Medialink and the American Heart Association: 'Better Fats' Benefit Heart Health 2Health News:Injected Medication Errors a Major Problem 2Health News:MESSA Receives National Recognition for Best Practices in Providing Efficient, Cost-Effective Customer Service 2Health News:MESSA Receives National Recognition for Best Practices in Providing Efficient, Cost-Effective Customer Service 3
... HmX offers three-dimensional ... sensitivity, specificity and efficiency ... and reticulocyte analysis. With ... and dependability, HmX is ...
Creatinine Test Kit (enzymatic), Wavelength: 340 nm. Linear range: up to 20 mg/dL....
For the quantitative determination of Creatine Kinase in serum....
For the qualitative determination of magnesium in serum....
Medicine Products: